TABLE 2.
Follow-up of vaccinations
Patient and no. of days postvaccination | RV-IgM index | RV-IgG IU/ml | RV-IgG avidity index (%)
|
|
---|---|---|---|---|
In-house method | VIDAS assay | |||
1 | ||||
0 | 0.24 | 1 | NDa | ND |
20 | 1.51 | 8 | ND | ND |
34 | 7.22 | 42 | 13 | 6 |
62 | 3 | 103 | 49 | 27 |
89 | 1.63 | 113 | 57 | 29 |
2 | ||||
0 | 0.08 | 1 | ND | ND |
24 | 7.3 | 12 | ND | ND |
68 | 3.33 | 44 | 29 | 10 |
81 | 1.98 | 64 | 45 | 22 |
3 | ||||
0 | 0.64 | 1 | ND | ND |
18 | 5.79 | 30 | 20 | 13 |
34 | 4.79 | 43 | 33 | 18 |
90 | 11.8 | 127 | 85 | 55 |
4 | ||||
0 | 0.1 | 0 | ND | ND |
38 | 7.42 | 66 | 32 | 13 |
51 | 4.49 | 77 | 47 | 18 |
66 | 3.04 | 93 | 66 | 29 |
94 | 1.62 | 118 | 75 | 42 |
5 | ||||
0 | 0.1 | 0 | ND | ND |
27 | 10.21 | 26 | 11 | 13 |
47 | 4.3 | 55 | 25 | 11 |
73 | 1.71 | 75 | 49 | 21 |
6 | ||||
18 | 1.64 | 7 | ND | ND |
22 | 7.12 | 51 | 18 | 3 |
31 | 3.6 | 88 | 25 | 7 |
46 | 1.1 | 84 | 40 | 15 |
7 | ||||
60 | 1.66 | 134 | 50 | 28 |
90 | 0.86 | 106 | 67 | 42 |
8 | ||||
150 | 3.49 | 169 | 65 | 50 |
176 | 2.86 | 157 | 72 | 53 |
ND, not done.